Andrew L Kung Selected Research

Secretory breast carcinoma

1/2018	Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
1/2017	Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew L Kung Research Topics

Disease

92	Neoplasms (Cancer) 01/2022 - 11/2003
22	Leukemia 01/2022 - 02/2003
11	Multiple Myeloma 10/2017 - 03/2004
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019 - 02/2005
10	Hypoxia (Hypoxemia) 01/2016 - 07/2003
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018 - 07/2007
9	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018 - 03/2011
9	Glioblastoma (Glioblastoma Multiforme) 05/2015 - 11/2003
8	Ewing Sarcoma (Sarcoma, Ewing) 01/2021 - 06/2006
8	Glioma (Gliomas) 01/2020 - 02/2006
7	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 03/2004
6	Breast Neoplasms (Breast Cancer) 08/2021 - 12/2006
5	Neuroblastoma 11/2021 - 07/2008
5	Carcinoma (Carcinomatosis) 10/2018 - 04/2011
4	Lung Neoplasms (Lung Cancer) 10/2018 - 03/2012
4	Inflammation (Inflammations) 06/2015 - 09/2012
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2010 - 02/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2014 - 08/2009
3	Endometriosis 07/2013 - 06/2006
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2012 - 12/2006
3	Clear Cell Sarcoma 10/2011 - 06/2006
3	Melanoma (Melanoma, Malignant) 10/2011 - 06/2006
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 04/2012
2	Secretory breast carcinoma 01/2018 - 01/2017
2	Medulloblastoma 11/2017 - 11/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2016 - 03/2015
2	Viremia 01/2016 - 11/2015
2	Liposarcoma 09/2014 - 05/2006
2	Adenocarcinoma of Lung 03/2014 - 12/2010
2	Neoplasm Metastasis (Metastasis) 08/2012 - 06/2012
2	Genetic Translocation (Chromosomal Translocation) 04/2012 - 06/2006
2	Disease Progression 08/2011 - 07/2007

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
15	Pharmaceutical PreparationsIBA 01/2018 - 01/2007
9	Phosphotransferases (Kinase)IBA 02/2014 - 03/2004
7	Bortezomib (Velcade)FDA Link 01/2020 - 02/2006
7	Oncogene Proteins (Oncogene Protein)IBA 10/2018 - 04/2007
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2013 - 03/2004
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2006
5	Histone Deacetylase InhibitorsIBA 05/2015 - 07/2008
5	Transcription Factors (Transcription Factor)IBA 02/2012 - 07/2003
4	Biological ProductsIBA 01/2021 - 03/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
4	RNA (Ribonucleic Acid)IBA 01/2018 - 10/2015
4	EnzymesIBA 01/2016 - 04/2009
4	Small Interfering RNA (siRNA)IBA 09/2014 - 05/2013
4	LigandsIBA 07/2012 - 12/2005
4	LuciferasesIBA 03/2012 - 02/2006
3	selinexorIBA 01/2020 - 04/2013
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2017 - 04/2014
3	Tyrosine (L-Tyrosine)FDA Link 05/2013 - 07/2007
3	nilotinib FDA Link 10/2012 - 03/2007
3	Histone Deacetylases (Histone Deacetylase)IBA 03/2012 - 07/2008
3	Hypoxia-Inducible Factor 1IBA 10/2011 - 01/2009
3	Lysine (L-Lysine)FDA Link 07/2011 - 11/2008
3	Histones (Histone)IBA 07/2011 - 11/2008
3	Imatinib Mesylate (Gleevec)FDA Link 04/2010 - 03/2007
3	plerixafor FDA Link 04/2009 - 11/2003
3	midostaurinIBA 12/2008 - 02/2003
2	Growth Factor ReceptorsIBA 08/2021 - 10/2017
2	WT161IBA 08/2021 - 10/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 02/2003
2	ChromatinIBA 01/2021 - 10/2018
2	Proteasome InhibitorsIBA 01/2020 - 02/2006
2	Exportin 1 ProteinIBA 01/2020 - 05/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2017 - 04/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2017 - 04/2012
2	Cyclin D3IBA 02/2017 - 10/2012
2	Everolimus FDA Link 02/2017 - 12/2006
2	Drug CombinationsIBA 02/2017 - 07/2007
2	ribociclibIBA 02/2017 - 09/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2016 - 03/2015
2	Firefly LuciferasesIBA 01/2015 - 02/2006
2	LuciferinsIBA 01/2015 - 02/2006
2	Adenosine Triphosphate (ATP)IBA 09/2014 - 05/2010
2	Anaplastic Lymphoma KinaseIBA 09/2014 - 12/2010
2	CrizotinibIBA 09/2014 - 03/2014
2	NVP-TAE684IBA 03/2014 - 12/2010
2	Deoxyglucose (2 Deoxy D glucose)IBA 02/2014 - 10/2012
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2013 - 12/2006
2	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 08/2013 - 09/2012
2	LuminolIBA 08/2013 - 09/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2013 - 05/2009
2	Messenger RNA (mRNA)IBA 07/2013 - 01/2009
2	Vascular Endothelial Growth Factor CIBA 07/2013 - 10/2011
2	CateninsIBA 06/2013 - 08/2012
2	Cadherins (E-Cadherin)IBA 06/2012 - 03/2009
2	Peptides (Polypeptides)IBA 06/2012 - 03/2004
2	CREB-Binding ProteinIBA 04/2012 - 07/2003
2	Vorinostat FDA Link 02/2012 - 04/2011
2	Microphthalmia-Associated Transcription FactorIBA 10/2011 - 08/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2011 - 09/2008
2	Insulin-Like PeptidesIBA 08/2011 - 03/2004
2	Inhibitor of Apoptosis ProteinsIBA 08/2011 - 09/2008
2	LBW242IBA 08/2011 - 07/2007

Therapy/Procedure

52	Therapeutics 01/2022 - 03/2004
11	Drug Therapy (Chemotherapy) 01/2022 - 03/2004
5	Cell Transplantation 01/2016 - 03/2015
3	Precision Medicine 01/2018 - 10/2016
3	Radiotherapy 06/2012 - 08/2011